146 related articles for article (PubMed ID: 2872793)
1. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.
Elkayam U; Roth A; Hsueh W; Weber L; Freidenberger L; Rahimtoola SH
Am Heart J; 1986 Jun; 111(6):1130-8. PubMed ID: 2872793
[TBL] [Abstract][Full Text] [Related]
2. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
3. Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure.
Ueda K; Sakai M; Matsushita S; Kuwajima I; Murakami M
Jpn Heart J; 1983 Sep; 24(5):711-21. PubMed ID: 6366290
[TBL] [Abstract][Full Text] [Related]
4. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
5. Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.
Leenen FH; Burns RJ; Myers MG; Frankel D
Cardiovasc Drugs Ther; 1990 Apr; 4(2):499-504. PubMed ID: 1981020
[TBL] [Abstract][Full Text] [Related]
6. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness.
Manthey J; Dietz R; Opherk D; Osterziel KJ; Leinberger H; Kübler W
Am J Cardiol; 1992 Jul; 70(2):224-8. PubMed ID: 1626511
[TBL] [Abstract][Full Text] [Related]
7. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Schofer J; Hobuss M; Aschenberg W; Tews A
Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
[TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH
J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724
[TBL] [Abstract][Full Text] [Related]
9. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
[TBL] [Abstract][Full Text] [Related]
11. Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension.
Pedersen OL; Mikkelsen E; Christensen NJ; Kornerup HJ; Pedersen EB
Eur J Clin Pharmacol; 1979 May; 15(4):235-40. PubMed ID: 477707
[TBL] [Abstract][Full Text] [Related]
12. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
13. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
[TBL] [Abstract][Full Text] [Related]
14. Co-dergocrine mesylate inhibits the increase in plasma catecholamines caused by nifedipine in essential hypertension.
Kirsten R; Nelson K; Weidinger G; Welzel D
Eur J Clin Pharmacol; 1990; 39(5):435-9. PubMed ID: 2076734
[TBL] [Abstract][Full Text] [Related]
15. Captopril in congestive heart failure resistant to other vasodilators.
Fouad FM; El-Tobgi S; Tarazi RC; Bravo EL; Hart NJ; Shirey EK; Lim J
Eur Heart J; 1984 Jan; 5(1):47-54. PubMed ID: 6368232
[TBL] [Abstract][Full Text] [Related]
16. Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
Kidney Int; 1985 Oct; 28(4):658-65. PubMed ID: 3910913
[TBL] [Abstract][Full Text] [Related]
17. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
Rouleau JL; Kortas C; Bichet D; de Champlain J
Am Heart J; 1988 Sep; 116(3):746-57. PubMed ID: 2970771
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
Lefkowitz CA; Moe GW; Armstrong PW
Am J Cardiol; 1987 Jan; 59(3):59B-63B. PubMed ID: 3101477
[TBL] [Abstract][Full Text] [Related]
20. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. I. Role of the adrenergic and dopaminergic systems].
Melloni R; Scarazatti E; Gandini C; Melloni GF
Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1113-20. PubMed ID: 3331289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
